SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Rafarma Pharmaceuticals Inc. (RAFA)

RAFA RSS Feed
Add RAFA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 7/3/2016 10:08:39 AM - Followers: 68 - Board type: Free - Posts Today: 0

Operating from our new state-of-the-art manufacturing and distribution facility in Terbuny, Lipetsk Region, Rafarma Pharmaceuticals produces generic antibiotics and specialty pharmaceuticals in addition to our own line of proprietary products that are approved by the Ministry of Health of Russian Federation.

For the last three years, the Russian Government has been highly focused on bolstering the development of Russia's domestic pharmaceutical industry. Our mission is to work with the auspices of aggressive federal initiatives to fast-track the modernization of Russia's pharmaceutical industry.

The Russian pharmaceutical market is estimated to be valued at $60 billion by 2020, representing annual growth of at least 15%. The market is far from the ceiling of its astounding potential, and at Rafarma Pharmaceuticals, we are wholly dedicated to capitalizing on the emerging opportunities for growth.

As one of the foremost research companies in Russia, we possess a unique niche within the country's growing pharmaceutical market, leveraging our world-class production facility and exciting product portfolio to carve our path to become a major player in the international drug industry.

Backed by a diverse pharmaceutical product portfolio, Rafarma Pharmaceuticals provides shareholders and clients the opportunity to share in the expansion of what we believe will be a pharmaceuticals industry giant.

Number of employees: 461

U.S. Company Website: www.Rafarma.com
Russian Company Website: www.Rafarma.ru

Presentation: Rafarma Presentation
Fact Sheet: Rafarma Fact Sheet

Rafarma News: Rafarma NEWS

Facebook: Rafarma Facebook Page
Twitter: Rafarma Twitter Profile


Rafarma Plant Photo Gallery
 




Investment Highlights 
  • Russian Government is focused bolstering domestic pharmaceutical market, supporting local companies
    Russian pharmaceutical sector expected to be valued at $10.7 billion by 2014, $60 billion by 2020
    Company expects to produce proprietary and new hi-tech pharmaceutical developments from its world-class research facilities
    Rafarma is the principle supplier to the Russian Public Health system and the Russian Army
    Company growth is aimed far beyond the Russian market to a global pharmaceutical reach
    Rafarma is currently applying to be quoted on the GXG market
    Despite its early development stage, Rafarma has been conservatively valued at circa US$300 million
 

 

Industry Foothold

Rafarma is positioned to capitalize and grow from two significant variables saddling the Eastern European Pharmaceuticals market: growing demand and a struggling economy. The population of elderly citizens throughout Eastern Europe has grown alongside the region's economic turmoil.

These factors equate to increased favorability from both healthcare providers and individuals pursuing high-quality yet affordable pharmaceutical products. In addition, Russian government mandates requiring physicians to use Rafarma products create a solid and unique niche within the pharmaceutical industry.

If the progress continues as the government plans, the Russian pharmaceutical industry by 2020 could contribute 50% of drugs in circulation, 80% of which would be domestically developed.

Rafarma is on track to saturate the Russian market as a European-based specialist pharmaceutical producer. Its initiatives don't stop there - the company is also securing its foothold penetrate international markets such as Brazilian and the Southeast Asian sub-continent.
 

 

 


 

Manufacturing and Distribution Facility

Rafarma Pharmaceuticals has invested considerable funds in building a state-of-the-art production facility in the economic development zone in Terbuny, Lipetsk Region, approximately 300 km south of Moscow.

This multi-profile pharmaceutical plant has the capability and space to produce all types and forms of medical drugs of various pharmacological groups.

The project has been supported by the government of Lipetsk region of Russia, Ministry of Health of Russian Federation, and the Ministry of Industry and Trade of Russian Federation, which listed Rafarma Pharmaceuticals as one of the leading and most prospective projects in the modern Russian pharmaceutical and medical industry.

Rafarma Pharmaceuticals' facility is being implemented in accordance with the government-developed Strategy of Development of Pharmaceutical Industry in Russia, which encourages the construction and improvement of modern production facilities in compliance with GMP standards to eliminate Russia's need to purchase certain pharmaceutical products outside of the country.

 


 

The Management Team

With highly experienced and ambitious leadership at the helm, Rafarma Pharmaceuticals has achieved rapid advancements in the pharmaceutical industry. The company's key management team is skilled with a diverse line of expertise that includes entrepreneurship, business management, international corporations, cash management, law, finance, corporate loans and more. Under the focused guidance of this core management team, Rafarma Pharmaceuticals is positioned to continue its progress and become a dominant figure in the Russian pharmaceutical market.

 

CEO and Director - Bruno Horn

Mr. Horn is the founder of his own consultancy based in Switzerland, specializing in steel trading and the pharmaceutical industry. Mr. Horn started his career as a trader in raw materials and semi-finished products, as well as, OEM products for Olivetti. Mr. Horn served as head of back office for Olivetti Group's financial operations. Mr. Horn was in charge of international flat steel trade structure for Olsher Metals, a US based group, before joining the Lucchini Group with their flat products sector and organizing the sales structure for the US. Mr. Horn, also served as independent consultant for CMM, a US based company active in the field of securitizations. Most recently, Mr. Horn was director of finance for MMK Steel of Russia. Mr. Horn brings significant experience in finance and operational management particularly in Russia markets. 



CFO and Director - Sergey Brusnitsin, JD, PhD

Sergey Brusnitsin came to Rafarma from the position of Vice-Chief of the Federal Revenue Service of Russia, Interregional Inspection. Mr. Brusnitsin carries both a law degree from Moscow Financial and Industrial Academy and a PhD from Moscow State Univesity of Economics, Statistics and Information Systems. Mr. Brusnitsin's dissertation was on management of cash flows and loans in international corporations. Mr. Brusnitsin is a valuable asset for Rafarma with his tremendous expertise in international corporations, law and finance.



Secretary Treasurer - Alexander Ageev, JD

Alexander Ageev specializes in state-legal and financial law. Prior to joining Rafarma Pharmaceuticals, Mr. Ageev worked as a court session specialist secretary, assistant judge in the Arbitration court of Moscow, deputy chief of the organizational-control department of the Administration of Federal services, among others. He currently is the deputy general director of legal issues and information security for CJSC "Rafarma" in addition to his role as Secretary-Treasurer of Rafarma Pharmaceuticals.
 


Share Structure

Market Value $4,076,681 a/o Apr 05, 2013
Shares Outstanding 83,894,399 a/o Oct 10, 2014
Float 11,287,187 a/o Oct 10, 2014
Authorized Shares 300,000,000 a/o Apr 01, 2013

Transfer Agent

Western States Transfer and Registrar, Inc.
1911 Ryan Park Avenue
Sandy, Utah 84092
1-801-523-1547

Projected Revenue Estimates
http://www.rafarma.com/praforma/

2012 - $15,606,285
2013 - $142,488,845
2014 - $271,488,845
2015 - $317,000,000


 

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RAFA
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#3959   and you never will. Big Brother 07/03/16 10:08:39 AM
#3958   still didn't get any shares from these scumbuckets Wayne R 07/02/16 05:52:59 PM
#3957   .0047 lil vol still holding. All i could gumzsa 06/06/16 12:41:58 PM
#3956   simple explaination. Wayne R 09/14/15 03:12:07 PM
#3955   Please explain SILVERISTHENEWGOLD 09/03/15 12:58:22 PM
#3954   Even on the good financial news released this timpanogis 08/27/15 10:52:21 AM
#3953   Wow! Please tell why? Labdai 08/26/15 10:34:05 AM
#3952   Trilife, no idea GO RAFA m0n 08/16/15 08:06:49 PM
#3951   ads contact ? GO RAFA m0n 08/16/15 07:25:45 PM
#3950   Anyone with specific questions about RAFA PLEASE PM fallin123 08/14/15 11:26:32 AM
#3949   not sure what you mean SILVERISTHENEWGOLD 08/13/15 07:24:05 PM
#3948   Is that you BigMoneyMike?? m0n 08/13/15 07:06:21 PM
#3947   Agree, news could push us to .10+ SILVERISTHENEWGOLD 08/13/15 04:02:40 PM
#3946   I agree, 7 filings ....news should follow RAFA m0n 08/13/15 01:35:07 PM
#3945   Some idiots still selling on the bid, mean stockstalk09 08/13/15 10:53:06 AM
#3944   RAFA 025 up P/M m0n 08/13/15 09:22:18 AM
#3943   $RAFA BRUTAL DOWN TREND MonopolyTrader 08/12/15 04:57:18 PM
#3942   A hole sells on bid one minute before stockstalk09 08/12/15 04:03:35 PM
#3941   RAFA 0188 fall 025 up m0n 08/12/15 03:16:44 PM
#3940   Does it matter? 0 volume......strange though CDRL moved m0n 08/12/15 02:42:19 PM
#3939   Hey retard who keeps moving lower on the stockstalk09 08/12/15 01:07:36 PM
#3938   RAFA MM BKRT gone off the ask m0n 08/12/15 11:42:04 AM
#3937   RAFA ASK THINNED AND MM BKRT IS AT 025 m0n 08/12/15 09:39:17 AM
#3936   RAFA 10k block bid whack followed w/ a m0n 08/12/15 07:07:06 AM
#3935   RAFA 10k block whack followed m0n 08/12/15 07:04:06 AM
#3934   It was starting to look like a big stockstalk09 08/11/15 03:46:33 PM
#3933   RAFA is gold IMO m0n 08/11/15 02:30:35 PM
#3932   RAFA QUIET BEFORE THE STORM IMO m0n 08/11/15 01:43:13 PM
#3931   Last time this happened we ran to 029! m0n 08/11/15 11:09:31 AM
#3930   Agreed! RAFA filings clearly state REVISED stockholder equity m0n 08/11/15 11:00:14 AM
#3929   Last of the losing flipbirds flew away with stockstalk09 08/11/15 10:54:43 AM
#3928   RAFA scare tactic to accumulated more cheapies IMO m0n 08/11/15 10:49:54 AM
#3927   RAFA WHACKtards m0n 08/11/15 10:45:14 AM
#3926   RAFA All green on the bid on L2 m0n 08/11/15 10:11:14 AM
#3925   added .0151s gumzsa 08/11/15 09:56:05 AM
#3924   a RAFA MM PUMA BIDDING m0n 08/11/15 09:52:22 AM
#3923   Is HDOG holding RAFA? Is HDOG sending out m0n 08/11/15 08:47:20 AM
#3922   017 was the shake yesterday then 02's got m0n 08/11/15 08:41:24 AM
#3921   Won't touch RAFA or GAZA. easymoney 08/11/15 04:13:45 AM
#3920   I added @ .017 janitor_unbound 08/10/15 03:26:24 PM
#3919   ~RAFA~ Buying more at these sub-02 prices, current SILVERISTHENEWGOLD 08/10/15 03:07:20 PM
#3918   added a few more RAFA .017s i really gumzsa 08/10/15 03:06:24 PM
#3917   Big profits takers in big movers today AQXP stockstalk09 08/10/15 02:50:13 PM
#3916   not much interest here? janitor_unbound 08/10/15 02:37:29 PM
#3915   Lol with the exception one is a big board! Read-Dark Pool 08/10/15 12:13:07 PM
#3914   MMs undercutting RAFA m0n 08/10/15 10:38:47 AM
#3913   I am ready spread the word ARTIST 08/10/15 10:29:16 AM
#3912   Look what happen to the sellers and shorters stockstalk09 08/10/15 10:25:26 AM
#3911   Great BMM and TEAMFAM are here GO RAFA m0n 08/10/15 10:24:51 AM
#3910   RAFA could be the next AQXP HDOGTX 08/10/15 10:20:46 AM
PostSubject